What Happened? Shares of medical device company Penumbra (NYSE:PEN) jumped 17.2% in the morning session after it reported third-quarter 2025 financial results that surpassed Wall Street's expectations for both revenue and profit. The company's revenue grew 17.8% year on year to $354.7 million, comfortably beating analysts' consensus estimate of$340.4 million. Its profitability also showed significant improvement, with non-GAAP earnings per share (EPS) of $0.97, which was 5.3% ahead of expectations. Penum ...